Critical Weeks Begin For Health Law Rollout

Kelly Ayotte (R., N.H.) said on Fox News Sunday that Mr. Obama needed to call a time out and meet with Democrats and Republicans and try to find a way to proceed. The White House is also battling news that some Americans who purchased individual health-insurance policies are getting cancellation notices, in contradiction to President Barack Obamas oft-repeated promise that people who liked their health plans could keep them. Perhaps the most important lesson the president, I think, failed to learn was you have to tell the American people the truth. And when he told the American people that you could keep your health insurance if you wanted to keep that plan, periodhe said that time and againhe wasnt telling the truth, said former Massachusetts Gov. Mitt Romney , Mr.
For the original version including any supplementary images or video, visit http://blogs.wsj.com/washwire/2013/11/03/critical-weeks-begin-for-health-law-rollout/

Digital health tools likely to decrease visits to the doctor

“When all of these likely effects are added together, it is clear that health IT will help resolve future physician shortages that many believe are around the corner,” said the study’s lead author Jonathan Weiner in a school news release. Another report in the same journal by the nonprofit research organization RAND Corp. also finds that the rise in use of physician assistants and nurse practitioners under Obamacare will help ease the burden of looming doctor shortages . Related stories New rules issued on electronic health records In a recent interview with CNET , Dr. Peter Antall, medical director of the Online Care Group who has been recruiting physicians to practice telemedicine for the past two years, said tools like telemedicine will be more widely practiced in time: “We really feel we’re developing a whole new way of practicing medicine, and it’s exciting. Patients do have to get comfortable with this, but I remember a time where we were worried about electronic banking, and we got over that.” The authors reviewed health informatics and health services research literature through June using MEDLINE, the Cochrane Database, and the Agency for Healthcare Research and Quality’s database on health IT.
For the original version including any supplementary images or video, visit http://news.cnet.com/8301-11386_3-57610765-76/digital-health-tools-likely-to-decrease-visits-to-the-doctor/

Genomic Health Announces Third Quarter 2013 Financial Results and Business Progress

(NASDAQ: GHDX ) is the world’s leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic datainto clinically-actionable results for treatment planning throughout the cancer patient’s journey, from screening and surveillance, through diagnosis, treatment selection and monitoring. Genomic Health’s lead product, the Oncotype DX breast cancer test , has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS) . In addition to this widely adopted test, Genomic Health provides the Oncotype DX colon cancer test , the first multi-gene expression test developed for the assessment of risk of recurrence in patients with stage II and stage III disease, and the Oncotype DX prostate cancer test , which predicts disease aggressiveness in men with low risk disease. As of September 30, 2013, more than 19,000 physicians in over 70 countries had ordered nearly 400,000 Oncotype DX tests. The company is based in Redwood City , California with European headquarters in Geneva, Switzerland. For more information, please visit, http://www.GenomicHealth.com and follow the company on Twitter: @GenomicHealth . To learn more about OncotypeDX tests , visit: http://www.OncotypeDX.com , http://www.mybreastcancertreatment.org and http://www.myprostatecancertreatment.org . This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company’s ability to undertake or complete additional studies; the success or results of clinical trials and the timing of such activities; the applicability of clinical study results to actual outcomes; the ability of the company’s tests to impact clinical practice; and the focus and attributes of the company’s product pipeline.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/genomic-health-announces-third-quarter-210100331.html

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s